BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35090330)

  • 21. Lobelia chinensis Lour inhibits the progression of hepatocellular carcinoma via the regulation of the PTEN/AKT signaling pathway in vivo and in vitro.
    Luo J; Chen QX; Li P; Yu H; Yu L; Lu JL; Yin HZ; Huang BJ; Zhang SJ
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116886. PubMed ID: 37429502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of "Hedyotis Diffusae Herba-Smilacis Glabrae Rhizoma" in treatment of lung adenocarcinoma based on network pharmacology].
    Li JL; Hou W
    Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(23):6261-6270. PubMed ID: 34951253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mechanism of Carthami Flos and Lepidii Semen drug pair in inhibition of myocardial fibrosis by improving cardiac microenvironment based on network pharmacology and animal experiment].
    Wang Y; Wang Z; Wang C; Ma DF
    Zhongguo Zhong Yao Za Zhi; 2022 Feb; 47(3):753-763. PubMed ID: 35178959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma.
    Xie Y; Yan F; Wang X; Yu L; Yan H; Pu Q; Li W; Yang Z
    Cancer Med; 2023 Feb; 12(3):3237-3259. PubMed ID: 36043445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification.
    Lu S; Meng Z; Tan Y; Wu C; Huang Z; Huang J; Fu C; Stalin A; Guo S; Liu X; You L; Li X; Zhang J; Zhou W; Zhang X; Wang M; Wu J
    BMC Complement Med Ther; 2022 Mar; 22(1):54. PubMed ID: 35236335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
    Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
    Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
    [No Abstract]   [Full Text] [Related]  

  • 27. Gigantol Targets MYC for Ubiquitin-proteasomal Degradation and Suppresses Lung Cancer Cell Growth.
    Losuwannarak N; Roytrakul S; Chanvorachote P
    Cancer Genomics Proteomics; 2020; 17(6):781-793. PubMed ID: 33099479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism underlying the effect of Pulsatilla decoction in hepatocellular carcinoma treatment: a network pharmacology and in vitro analysis.
    Liu K; Cao Z; Huang S; Kong F
    BMC Complement Med Ther; 2023 Nov; 23(1):405. PubMed ID: 37950195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systems Pharmacology-Based Strategy to Investigate the Mechanism of Ruangan Lidan Decoction for Treatment of Hepatocellular Carcinoma.
    Chen C; Liang T; Wu Q; Zhou Z; Zhang M; Feng D; Tao J; Si T; Cai M
    Comput Math Methods Med; 2022; 2022():2940654. PubMed ID: 36578460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In Silico and In Vitro Studies on the Mechanisms of Chinese Medicine Formula (Yiqi Jianpi Jiedu Formula) in the Treatment of Hepatocellular Carcinoma.
    Wu Z; Kang J; Tan W; Wei C; He L; Jiang X; Peng L
    Comput Math Methods Med; 2022; 2022():8669993. PubMed ID: 36345477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-osmotic and antioxidant activities of gigantol from Dendrobium aurantiacum var. denneanum against cataractogenesis in galactosemic rats.
    Fang H; Hu X; Wang M; Wan W; Yang Q; Sun X; Gu Q; Gao X; Wang Z; Gu L; Oliver Chen CY; Wei X
    J Ethnopharmacol; 2015 Aug; 172():238-46. PubMed ID: 26119284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring the mechanisms underlying the therapeutic effect of the
    Qing L; Pan B; He Y; Liu Y; Zhao M; Niu B; Gao X
    Aging (Albany NY); 2022 Nov; 14(22):9103-9127. PubMed ID: 36403263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local anesthetic bupivacaine inhibits proliferation and metastasis of hepatocellular carcinoma cells via suppressing PI3K/Akt and MAPK signaling.
    Wang L; Guo W; Guan H; Yan N; Cai X; Zhu L
    J Biochem Mol Toxicol; 2021 Oct; 35(10):e22871. PubMed ID: 34338398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
    J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Network Pharmacology-Based Approach Combined with Bioinformatic Analytics to Elucidate the Potential of Curcumol against Hepatocellular Carcinoma.
    Huang X; Rehman HM; Szöllősi AG; Zhou S
    Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anhydroicaritin suppresses tumor progression via the PI3K/AKT signaling pathway in hepatocellular carcinoma.
    Wang H; Chen W; Cui Y; Gong H; Tang A
    Aging (Albany NY); 2023 Aug; 15(15):7831-7843. PubMed ID: 37556351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring the mechanism of Jianpi Huatan recipe in protecting hepatocellular carcinoma based on network pharmacology.
    Zhang C; Xiang H; Wang J; Shao G; Ding P; Gao Y; Xu H; Ji G; Wu T
    J Ethnopharmacol; 2023 Dec; 317():116676. PubMed ID: 37279814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gigantol inhibits Wnt/β-catenin signaling and exhibits anticancer activity in breast cancer cells.
    Yu S; Wang Z; Su Z; Song J; Zhou L; Sun Q; Liu S; Li S; Li Y; Wang M; Zhang GQ; Zhang X; Liu ZJ; Lu D
    BMC Complement Altern Med; 2018 Feb; 18(1):59. PubMed ID: 29444668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An investigation into the mechanism of nobiletin's inhibition of papillary thyroid cancer using network pharmacology analysis and experimental pharmacology.
    Du QJ; Li Q; Zhou RH; Wang H; Yan Q; Dang WJ; Guo JJ
    Eur Rev Med Pharmacol Sci; 2023 Feb; 27(4):1553-1564. PubMed ID: 36876711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring the effect of Gupi Xiaoji Prescription on hepatitis B virus-related liver cancer through network pharmacology and in vitro experiments.
    Yu S; Gao W; Zeng P; Chen C; Zhang Z; Liu Z; Liu J
    Biomed Pharmacother; 2021 Jul; 139():111612. PubMed ID: 33915505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.